Literature DB >> 2295834

Immunosuppression by factors released from UV-irradiated epidermal cells: selective effects on the generation of contact and delayed hypersensitivity after exposure to UVA or UVB radiation.

T Y Kim1, M L Kripke, S E Ullrich.   

Abstract

Exposure of murine epidermal cells to UV radiation in vitro causes the release of immunoregulatory factors that mimic some of the immunosuppressive effects of in vivo UV irradiation. The purpose of this study was to investigate the spectrum of immune responses affected following i.v. injection of supernatants obtained from cultures of epidermal cells exposed in vitro to UV radiation. Treatment of primary epidermal cell cultures or transformed keratinocytes (Pam 212 cells) with UVB (280-320 nm) radiation caused the release of factors that suppressed the induction of delayed hypersensitivity to alloantigen and trinitrophenyl-modified self-antigens in syngeneic and allogeneic mice. Contrary to expectations, however, the injection of supernatants from UVB-irradiated epidermal cells had no effect on the induction of contact hypersensitivity to trinitrochlorobenzene. On the other hand, treatment of the keratinocytes with UVA radiation (320-400 nm, filtered to remove wavelengths in the UVB region) resulted in the release of a factor that suppressed contact but not delayed hypersensitivity. Neither the UVA-induced nor the UVB-induced suppressive factor inhibited the generation of an antibody response to sheep erythrocytes, indicating that, like the suppression that occurs after in vivo exposure to UV radiation, the suppression induced by factors from UV-irradiated keratinocytes is selective in nature. These data support the hypothesis that soluble keratinocyte-derived suppressive factors are involved in the induction of systemic immune suppression by UV radiation. In addition, they suggest that multiple suppressive factors, having different immunosuppressive properties, are produced by different wavelengths of UV radiation.

Entities:  

Mesh:

Year:  1990        PMID: 2295834     DOI: 10.1111/1523-1747.ep12873322

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  The effect of 1,25(OH)2-vitamin D3 on Langerhans cells and contact hypersensitivity in mice.

Authors:  Z Guo; H Okamoto; S Imamura
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

2.  Graft-versus-host disease: part II. Management of cutaneous graft-versus-host disease.

Authors:  Sharon R Hymes; Amin M Alousi; Edward W Cowen
Journal:  J Am Acad Dermatol       Date:  2012-04       Impact factor: 11.527

3.  The immune-modulating cytokine and endogenous Alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation.

Authors:  Scott Napier Byrne; Clare Beaugie; Clare O'Sullivan; Sarah Leighton; Gary M Halliday
Journal:  Am J Pathol       Date:  2011-05-13       Impact factor: 4.307

4.  Topical and oral retinoids protect Langerhans' cells and epidermal Thy-1+ dendritic cells from being depleted by ultraviolet radiation.

Authors:  K K Ho; G M Halliday; R S Barnetson
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

5.  Effects of acute, low-dose UVB radiation on the induction of contact hypersensitivity to diphenylcyclopropenone in man.

Authors:  A Friedli; T Hunziker; B Finkel; L R Braathen
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

6.  The effect of ultraviolet B irradiation and urocanic acid isomers on dendritic cell migration.

Authors:  A M Moodycliffe; I Kimber; M Norval
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

7.  Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice.

Authors:  M L Kripke; P A Cox; L G Alas; D B Yarosh
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

Review 8.  The Aryl Hydrocarbon Receptor in the Pathogenesis of Environmentally-Induced Squamous Cell Carcinomas of the Skin.

Authors:  Christian Vogeley; Katharina M Rolfes; Jean Krutmann; Thomas Haarmann-Stemmann
Journal:  Front Oncol       Date:  2022-03-03       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.